Champions Oncology (CSBR) Capital Expenditures Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Champions Oncology |
82.77 Mn |
75.76 Mn |
13.89 Mn |
-38.90% |
| Date | Value |
|---|
| Jan 31, 2026 |
-38.90% |
| Oct 31, 2025 |
-26.79% |
| Jul 31, 2025 |
-60.63% |
| Apr 30, 2025 |
-50.60% |
| Jan 31, 2025 |
-30.49% |
| Jan 31, 2024 |
-37.88% |
| Oct 31, 2023 |
-46.15% |
| Jul 31, 2023 |
-2.38% |
| Apr 30, 2023 |
50.75% |
| Jan 31, 2023 |
63.98% |
| Oct 31, 2022 |
67.04% |
| Jul 31, 2022 |
0.22% |
| Apr 30, 2022 |
-15.34% |
| Jan 31, 2022 |
41.50% |
| Oct 31, 2021 |
27.20% |
| Jul 31, 2021 |
62.60% |
| Apr 30, 2021 |
59.11% |
| Jan 31, 2021 |
152.19% |
| Oct 31, 2020 |
151.00% |
| Jul 31, 2020 |
-7.60% |
